Dr. Avinash Singh, FCCP, MD

Dr. Singh practices at Inspire ENT and Pulmonology PA in Manhattan, Kansas.

Dr. Singh's NPI, 1730383985, was assigned on June 12, 2007. Dr. Singh holds Kansas license 04-32404.

Dr. Singh's primary practice is Inspire ENT and Pulmonology PA, at 4201 Anderson Ave, Manhattan, KS 66503 in Riley County. The practice phone is (785) 539-3504.

Dr. Singh's primary practice is Inspire ENT and Pulmonology PA in Manhattan, Kansas. Dr. Singh is also affiliated with Ascension Via Christi Hospital in Manhattan. The medical group on file is Ascension Via Christi Hospital in Manhattan. Dmand AI also links Dr. Singh to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singh practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Singh's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Singh is licensed in Kansas.

CMS data shows 4,311 Medicare services from Dr. Singh across 25 procedure codes in 2024, for 514 Medicare patients. Medicare paid $115,717 for them.

CMS counts 514 Medicare patients who saw Dr. Singh in 2024. The largest group is 65 to 74, with 226 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Singh's median patient age at 64, with 55% women.

In 2024, Dr. Singh wrote 1,511 Medicare Part D claims for 272 patients. 38% of them were for generic drugs. CMS names the drug for 1,354 of them, across 28 drugs with 11 or more claims each, at $774,164 in total drug cost. In 2023, CMS named 1,404 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 22 out of 100 for Dr. Singh for performance year 2024, reported individually. Dr. Singh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Singh, published from 2019 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Bacterial Proteins, Neisseria gonorrhoeae and Phosphorylation. Dr. Singh has published most often in J Biol Chem. Dr. Singh's most frequent co-authors are Lawrence B. Holzman, MD, Daniel J. Lenihan, MD and Joshua Henry Lipschutz, MD.

CMS Open Payments shows 760 general payments to Dr. Singh from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. Grifols Shared Services North America, Inc. paid the most, $14,565.